Literature DB >> 29228516

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Alexander Kautzky1, Markus Dold1, Lucie Bartova1, Marie Spies1, Thomas Vanicek1, Daniel Souery2, Stuart Montgomery3, Julien Mendlewicz4, Joseph Zohar5, Chiara Fabbri6, Alessandro Serretti6, Rupert Lanzenberger1, Siegfried Kasper7,1.   

Abstract

OBJECTIVE: The study objective was to generate a prediction model for treatment-resistant depression (TRD) using machine learning featuring a large set of 47 clinical and sociodemographic predictors of treatment outcome.
METHOD: 552 Patients diagnosed with major depressive disorder (MDD) according to DSM-IV criteria were enrolled between 2011 and 2016. TRD was defined as failure to reach response to antidepressant treatment, characterized by a Montgomery-Asberg Depression Rating Scale (MADRS) score below 22 after at least 2 antidepressant trials of adequate length and dosage were administered. RandomForest (RF) was used for predicting treatment outcome phenotypes in a 10-fold cross-validation.
RESULTS: The full model with 47 predictors yielded an accuracy of 75.0%. When the number of predictors was reduced to 15, accuracies between 67.6% and 71.0% were attained for different test sets. The most informative predictors of treatment outcome were baseline MADRS score for the current episode; impairment of family, social, and work life; the timespan between first and last depressive episode; severity; suicidal risk; age; body mass index; and the number of lifetime depressive episodes as well as lifetime duration of hospitalization.
CONCLUSIONS: With the application of the machine learning algorithm RF, an efficient prediction model with an accuracy of 75.0% for forecasting treatment outcome could be generated, thus surpassing the predictive capabilities of clinical evaluation. We also supply a simplified algorithm of 15 easily collected clinical and sociodemographic predictors that can be obtained within approximately 10 minutes, which reached an accuracy of 70.6%. Thus, we are confident that our model will be validated within other samples to advance an accurate prediction model fit for clinical usage in TRD. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29228516     DOI: 10.4088/JCP.16m11385

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases.

Authors:  Michele Fornaro; Andrea Fusco; Stefano Novello; Pierluigi Mosca; Annalisa Anastasia; Antonella De Blasio; Felice Iasevoli; Andrea de Bartolomeis
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

2.  Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.

Authors:  Naji C Salloum; Maurizio Fava; Rebecca S Hock; Marlene P Freeman; Martina Flynn; Bettina Hoeppner; Cristina Cusin; Dan V Iosifescu; Madhukar H Trivedi; Gerard Sanacora; Sanjay J Mathew; Charles Debattista; Dawn F Ionescu; George I Papakostas
Journal:  J Affect Disord       Date:  2019-09-03       Impact factor: 4.839

3.  Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder.

Authors:  Drishti Shah; Wanhong Zheng; Lindsay Allen; Wenhui Wei; Traci LeMasters; Suresh Madhavan; Usha Sambamoorthi
Journal:  Curr Med Res Opin       Date:  2021-03-24       Impact factor: 2.580

4.  AI in patient flow: applications of artificial intelligence to improve patient flow in NHS acute mental health inpatient units.

Authors:  Fatema Mustansir Dawoodbhoy; Jack Delaney; Paulina Cecula; Jiakun Yu; Iain Peacock; Joseph Tan; Benita Cox
Journal:  Heliyon       Date:  2021-05-12

5.  Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis.

Authors:  Vincent Bremer; Dennis Becker; Spyros Kolovos; Burkhardt Funk; Ward van Breda; Mark Hoogendoorn; Heleen Riper
Journal:  J Med Internet Res       Date:  2018-08-21       Impact factor: 5.428

Review 6.  Prognosis and improved outcomes in major depression: a review.

Authors:  Christoph Kraus; Bashkim Kadriu; Rupert Lanzenberger; Carlos A Zarate; Siegfried Kasper
Journal:  Transl Psychiatry       Date:  2019-04-03       Impact factor: 6.222

7.  Analysis of Features Selected by a Deep Learning Model for Differential Treatment Selection in Depression.

Authors:  Joseph Mehltretter; Colleen Rollins; David Benrimoh; Robert Fratila; Kelly Perlman; Sonia Israel; Marc Miresco; Marina Wakid; Gustavo Turecki
Journal:  Front Artif Intell       Date:  2020-01-21

8.  Prediction of evening fatigue severity in outpatients receiving chemotherapy: less may be more.

Authors:  Kord M Kober; Ritu Roy; Anand Dhruva; Yvette P Conley; Raymond J Chan; Bruce Cooper; Adam Olshen; Christine Miaskowski
Journal:  Fatigue       Date:  2021-02-16

Review 9.  Addressing heterogeneity (and homogeneity) in treatment mechanisms in depression and the potential to develop diagnostic and predictive biomarkers.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2019-08-28       Impact factor: 4.881

10.  Combining machine learning algorithms for prediction of antidepressant treatment response.

Authors:  Alexander Kautzky; Hans-Juergen Möller; Markus Dold; Lucie Bartova; Florian Seemüller; Gerd Laux; Michael Riedel; Wolfgang Gaebel; Siegfried Kasper
Journal:  Acta Psychiatr Scand       Date:  2020-11-27       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.